Price Hike Scrutiny May Land Drug Cos. In Antitrust Hot Water
By Melissa Lipman ( October 8, 2015, 7:09 PM EDT) -- Turing Pharmaceuticals' decision to exponentially increase the price of a drug used to treat complications of AIDS prompted widespread outrage, but reports that the specialty drugmaker has restricted access to the drug to thwart generic competition could land the company — and others that use the same tactic — in antitrust trouble....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.